As someone stated above, the non-binding agreements are unlikely to be converted to binding until the results of TIVAN are in.
Pin up a dartboard, put a yearly calender on it and throw it. Thats when Tivan results are due.
My honest guess is that TIVAN testing is being completed in conjunction with the overall DFS (ie both will be completed at the same time) - which means end of 2014 or 4or 5months for results.
If we have 'binding' agreements before then they will be highly conditional on TIVAN etc (and therefore worth just about as much as non-binding agreements).
I very much doubt we will have binding agreements before then, as the non-binding agreements are all that is required until TIVAN 100% proven. We have proposed partners going forward, its just a matter of crunching the numbers when all the results are known. It is impossible for Hyundai to offer finance without knowing all the facts (DFS).
Those here who have held for years will continue to look on happily and top up at whatever level they see fit. Hindsight should ultimately prove 23 cents is a bargain, but for me (already have my fill with an average buy price ~ 10cents) I am content to wait a little longer and see exactly where this settles over the next few weeks before topping up another parcel.
There is plenty of other short term price price catalysts which may occur to give us small jumps in the SP, but I feel like the overall mood hence forth will be 'waiting on DFS'.
I am eagerly looking forward to the next quarterly (due any time in the next couple of weeks?) - hopefully with some finer details on DFS and TIVAN etc and not just a pure retelling of what we have been following very closely the past few months.
- Forums
- ASX - By Stock
- TVN
- TNG ... MC of $1B ... why not?
TNG ... MC of $1B ... why not?, page-60
-
-
- There are more pages in this discussion • 21 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add TVN (ASX) to my watchlist
(20min delay)
|
|||||
Last
5.7¢ |
Change
-0.002(3.39%) |
Mkt cap ! $98.20M |
Open | High | Low | Value | Volume |
5.9¢ | 5.9¢ | 5.7¢ | $60.52K | 1.032M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
7 | 655737 | 5.7¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
5.9¢ | 8153 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 83050 | 0.059 |
9 | 681539 | 0.057 |
6 | 555883 | 0.056 |
4 | 363234 | 0.055 |
2 | 143425 | 0.054 |
Price($) | Vol. | No. |
---|---|---|
0.052 | 27000 | 1 |
0.059 | 8153 | 1 |
0.060 | 45500 | 1 |
0.062 | 228000 | 2 |
0.063 | 100000 | 1 |
Last trade - 16.10pm 15/07/2024 (20 minute delay) ? |
Featured News
TVN (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online